Lithium Carbonate Tablet, Extended Release
Product Images NDC 70518-0608

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lithium Carbonate (NDC 70518-0608). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lithium Carbonate 300mg 70518 0608 00

Lithium Carbonate  300mg 70518 0608 00
This is a medication named Lithium Carbonate with extended-release, in a 300mg tablet form. The package quantity is 30 and the prescription is necessary. The NDC number is 70518-0608-00 5 and the lot number and expiration date are not available. The medication is manufactured by Rising Pharma in Allendale, NJ 07401 and repackaged by RemedyRepack Inc. in Indiana, PA 15701. The medication should be kept away from children and stored at a temperature between 20-25°C [58-77°F); excursions permitted to 15-30°C (59-86°F) [See USP]. The package insert contains the directions for use.*
FDA Label Image

Lithium Carbonate 300mg 70518 0608 01

Lithium Carbonate  300mg 70518 0608 01
Lithium Carbonate is an extended-release medication in tablet form with a strength of 300 mg. This medication is available in a quantity of 100 tablets and is only available through prescription. The NDC number for this medication is 70518-0608-01 and it expires with a specific LOT #. The manufacturer for this medication is Rising Pharma, Inc., located in Allendale, NJ. It should be kept out of reach of children, and the directions and warnings for this medication should be followed as outlined in the package insert. This medication should be stored at a temperature between 20-25°C (58-77°F) with excursions permitted to 15-30°C (59-86°F) [See USP]. The medication is repackaged by RemedyRepack Inc., located in Indiana, PA.*
FDA Label Image

Lithium Carbonate 300mg 70518 0608 02

Lithium Carbonate  300mg 70518 0608 02
Lithium Carbonate Extended-Release is a medication in tablet form with a dose of 300mg. It is RX Only and should be kept out of reach of children. The directions for use can be found in the package insert, and it should be stored at a temperature between 20-25°C (58-77°F) with some excursions up to 15-30°C (59-86°F). The product was repackaged by RemedyRepack Inc. located in Indiana, PA. The Lot number and Expiration date are not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.